Picture of Progyny logo

PGNY — Progyny News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapSuper Stock

Progyny Inc reports results for the quarter ended in January - Earnings Summary

* Progyny Inc  PGNY.OQ  reported quarterly adjusted earnings
of 17
cents​​ per share for the quarter ended in January, higher than
the same quarter last year, when the company reported EPS of 15
cents.  The mean expectation of eleven analysts for the quarter
was for earnings of 17 cents per share. Wall Street expected
results to range from 14 cents to 19 cents per share.
    * Revenue rose 8.8% to $304.09 million from a year ago;
analysts
expected $305.42 million. 
    * Progyny Inc's reported EPS for the quarter was 17 cents​.
    * The company reported quarterly net income of $16.49
million.
    * Progyny Inc shares had fallen by 11.5% this quarter and
lost 31.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 8.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the managed
healthcare
peer group is also "buy"

Wall Street's median 12-month price target for Progyny Inc is
$37.00 
This summary was machine generated from LSEG data August 6 at
10:21 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      0.17           0.17           Met
 Mar. 31 2024      0.13           0.17           Beat
 Dec. 31 2023      0.11           0.13           Beat
 Sep. 30 2023      0.12           0.16           Beat

Recent news on Progyny

See all news